Evidence map›Paper›PMID 31993564›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2019

Interest in Tobacco Treatment Delivered During Rideshare Travel.

Jonathan Shuter, Angie Yang, Ryung S Kim, John S Brownstein

Abstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan ShuterDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY.
Angie YangBronx High School of Science, NY.
Ryung S KimDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY.
John S BrownsteinDepartment of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA.

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
NCI NIH HHS P30 CA013330
6 · The paper itself

Abstract

More than 37,000,000 US adults smoke cigarettes. Most are interested in quitting, but rates of successful cessation remain low. Developing more and better approaches to tobacco treatment is a public health priority. The evolution of vehicular travel may present an opportunity for tobacco treatment intervention. We recruited individuals who reported previous use of ridesharing services (eg, Uber or Lyft) at 10 sites in the Boston area. They completed an anonymous survey that collected sociodemographic and tobacco use information and assessed participants' interest in receiving various forms of tobacco treatment during their rideshare rides. Forty-nine adult smokers completed the survey. Mean age = 40.1, 61.2% male, 51.0% white, 16.3% African American/black, 14.3% Latino, and 8.2% Asian. Almost 70% were college graduates, 79.6% worked full time, and 40.8% used ridesharing services ≥ weekly. They smoked a mean of 8.7 cigarettes per day; 35.3% were moderately or highly nicotine dependent, 36.7% also smoked cigars, 34.7% also used e-cigarettes, and 41.7% were in the contemplation or preparation stage of quitting. More than 56% of participants expressed some level of interest in receiving quit-smoking messaging during their rideshare rides. On multivariate analysis, black or Latino race/ethnicity and rideshare frequency of at least once a week were associated with interest in receiving quit-smoking messaging during rideshare rides. The majority of rideshare users who smoke are amenable to the idea of quit-smoking messaging delivered to them during their rides, and interest rates were highest among black or Latino riders and those who used rideshare services most frequently.

Indexed as

CI, confidence intervalOR, odds ratio

Identifiers

PMID31993564
PMCPMC6978606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.